Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfentanil plus remimazolam sedation for laryngeal mask anesthesia
ChiCTR2200064130Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam and alfentanil in Not applicable (2 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoint: Time from remimazolam induction to loss of consciousness. Planned start Sep 2022; status: not yet recruiting.
02
Drugs
remimazolamalfentanil
03
Conditions
Not applicable
Beyond the preview
Go deeper on ChiCTR2200064130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200064130.